Long-term slow-release theophylline significantly improved lung function, increasing FEV1 and PEF by up to 20% in asthma and 14% in COPD patients. The formulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: